QLT Acquires Early-Stage Ophthalmic Asset for US$7.5 Million
DEC 22
QLT Inc. Establishes Sales Force in the United States
DEC 15
QLT Initiates Phase Ib of QLT091001 in Leber Congenital Amaurosis
DEC 09
6-Month Results From EVEREST Study Evaluating Visudyne® Therapy in Patients with Polypoidal Choroidal Vasculopathy
2009 Q4 & Year-end Results Conference Call QLT will hold an investor call to discuss Q4 and year-end 2009 financial results on Wednesday, March 10 at 8:30 am ET. To receive an e-mail reminder for the call, click here.
2009 Q3 Results Conference Call QLT held an investor call to discuss Q3 2009 financial results on Tuesday, October 27 at 8:30 am ET. To listen to a replay of the webcast, click here.
HEAD OFFICE: QLT Inc., 887 Great Northern Way, Suite 101, Vancouver, BC, Canada, V5T 4T5 | t 800.663.5486
